| Literature DB >> 34335784 |
Belayneh Regasa Dadi1, Eyayu Girma1, Mheret Tesfaye1, Mohamed Seid1.
Abstract
BACKGROUND: Antimicrobials used for the treatment and prevention of bacterial infections are mainly released nonmetabolized into the aquatic environment via wastewater. Sometimes, unused therapeutic drugs are released down the drains that could act as selective pressure for the development of resistance. The aim of this study was to assess the bacteriological profile of wastewater in health facilities and determine antibiotic susceptibility patterns of bacterial isolates.Entities:
Year: 2021 PMID: 34335784 PMCID: PMC8298170 DOI: 10.1155/2021/9969479
Source DB: PubMed Journal: Int J Microbiol
Frequency of bacterial isolates from influent and effluent wastewater released from health facilities.
| Bacterial isolates | Arba Minch Hospital | Sikella Health Center effluent frequency (%) | Secha Health Center effluent frequency (%) | Total frequency (%) | |
|---|---|---|---|---|---|
| Influent frequency (%) | Effluent frequency (%) | ||||
|
| 7 (17.5) | 4 (15.4) | 3 (33.3) | 2 (33.3) | 16 (19.8) |
|
| 6 (15) | 5 (19.2) | 2 (22.2) | 2 (33.3) | 15 (18.5) |
|
| 5 (12.5) | 4 (15.4) | 2 (22.2) | 2 (33.3) | 13 (16) |
|
| 5 (12.5) | 4 (15.4) | 1 (11.1) | — | 10 (12.3) |
|
| 5 (12.5) | 2 (7.7) | 1 (11.1) | — | 8 (9.9) |
|
| 4 (10) | 3 (11.5) | — | — | 7 (8.6) |
| Coagulase-negative | 3 (7.5) | 2 (7.7) | — | — | 5 (6.2) |
|
| 3 (7.5) | 2 (7.7) | — | — | 5 (6.2) |
|
| 2 (5) | — | — | — | 2 (2.5) |
| Total | 40 (100) | 26 (100) | 9 (100) | 6 (100) | 81 (100) |
Antibiotic susceptibility patterns of bacterial isolates from influent wastewater released from Arba Minch Hospital.
| Bacterial isolates | Antimicrobial agents (frequency (percentage)) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMC | AMP | CPR | CTR | CHL | CTX | GN | TET | KAN | DOX | ERY | ||
|
| S | — | 0 (0) | 2 (40) | 0 (0) | 2 (40) | 2 (40) | 3 (60) | — | 3 (60) | — | — |
| I | — | 1 (20) | 2 (40) | 3 (60) | 1 (20) | 1 (20) | 1 (20) | — | 0 (0) | — | — | |
| R | — | 4 (80) | 1 (20) | 2 (40) | 2 (40) | 2 (40) | 1 (20) | — | 2 (40) | — | — | |
|
| ||||||||||||
|
| S | 3 (50) | 0 (0) | 2 (33) | 3 (50) | 3 (50) | 2 (33) | 3 (50) | 1 (17) | 2 (33) | 1 (17) | — |
| I | 0 (0) | 0 (0) | 2 (33) | 2 (33) | 3 (50) | 2 (33) | 2 (33) | 2 (33) | 2 (33) | 2 (33) | — | |
| R | 3 (50) | 6 (100) | 2 (33) | 1 (17) | 0 (0) | 2 (33) | 1 (17) | 3 (50) | 2 (33) | 3 (50) | — | |
|
| ||||||||||||
|
| S | 3 (60) | 1 (20) | 3 (60) | 2 (40) | 3 (60) | 2 (40) | 2 (40) | 2 (40) | 4 (80) | 1 (20) | — |
| I | 0 (0) | 0 (0) | 2 (40) | 1 (20) | 1 (20) | 1 (20) | 2 (40) | 1 (20) | 1 (20) | 2 (40) | — | |
| R | 2 (40) | 4 (80) | 0 (0) | 2 (40 | 1 (20) | 2 (40) | 1 (20) | 2 (40) | 0 (0) | 2 (40) | — | |
|
| ||||||||||||
|
| S | 3 (75) | 0 (0) | 2 (50) | 2 (50) | 2 (50) | 2 (50) | 2 (50) | 2 (50) | 2 (50) | 2 (50) | — |
| I | 0 (0) | 1 (25) | 2 (50) | 1 (25) | 2 (50) | 0 (0) | 0 (0) | 0 (0) | 2 (50) | 1 (25) | — | |
| R | 1 (25) | 3 (75) | 0 (0) | 1 (25) | 0 (0) | 2 (50) | 2 (50) | 2 (50) | 0 (0) | 1 (25) | — | |
|
| ||||||||||||
|
| S | 2 (40) | 1 (20) | 2 (40) | 2 (40) | 4 (80) | 2 (40) | 2 (40) | 2 (40) | 3 (60) | 2 (40) | — |
| I | 1 (20) | 1 (20) | 3 (60) | 1 (20) | 1 (20) | 1 (20) | 2 (40) | 1 (20) | 2 (40) | 1 (20) | — | |
| R | 2 (40) | 3 (60) | 0 (0) | 2 (40) | 0 (0) | 2 (40) | 1 (20) | 2 (40) | 0 (0) | 2 (40) | — | |
|
| ||||||||||||
|
| S | 2 (29) | 1 (20) | 3 (43) | 4 (57) | 6 (72) | 3 (43) | 4 (57) | 0 (0) | — | — | 3 (43) |
| I | 1 (14) | 0 (0) | 2 (29) | 0 (0) | 1 (14) | 2 (29) | 0 (0) | 4 (57) | — | — | 1 (14) | |
| R | 4 (57) | 6 (80) | 2 (29) | 3 (43) | 1 (14) | 2 (29) | 3 (43) | 3 (43) | — | — | 3 (43) | |
|
| ||||||||||||
| Coagulase-negative | S | 1 (33) | 0 (0) | 2 (67) | 2 (67) | 2 (67) | 1 (33) | 2 (67) | 0 (0) | — | — | 1 (33) |
| I | 0 (0) | 0 (0) | 1 (33) | 1 (33) | 1 (33) | 1 (33) | 1 (33) | 2 (67) | — | — | 0 (0) | |
| R | 2 (67) | 3 (100) | 0 (0) | 0 (0) | 0 (0) | 1 (33) | 0 (0) | 1 (33) | — | — | 2 (67) | |
|
| ||||||||||||
|
| S | 3 (100) | 0 (0) | 2 (67) | 1 (33) | 2 (67) | 1 (33) | 2 (67) | 0 (0) | — | 0 (0) | — |
| I | 0 (0) | 1 (33) | 1 (33) | 1 (33) | 0 (0) | 1 (33) | 1 (33) | 1 (33) | — | 1 (33) | — | |
| R | 0 (0) | 2 (67) | 0 (0) | 1 (33) | 1 (33) | 1 (33) | 0 (0) | 2 (67) | — | 2 (67) | — | |
AMC: amoxicillin; AMP: ampicillin; CPR: ciprofloxacin; CTR: ceftriaxone; CHL: chloramphenicol; CTX: ceftazidime; GN: gentamycin; TET: tetracycline; KAN: kanamycin; DOX: doxycycline; ERY: erythromycin; S: susceptible; I: intermediate; R: resistant.
Antibiotic susceptibility patterns of bacterial isolates from effluent released from Arba Minch Hospital.
| Bacterial isolates | Antimicrobial agent (frequency (percentage)) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMC | AMP | CPR | CTR | CHL | CTX | GN | TET | KAN | DOX | ERY | ||
|
| S | — | 0 (0) | 3 (75) | 2 (50) | 2 (50) | 0 (0) | 3 (75) | — | 3 (75) | — | — |
| I | — | 1 (25) | 0 (0) | 2 (50) | 1 (25) | 2 (50) | 0 (0) | — | 0 (0) | — | — | |
| R | — | 3 (75) | 1 (25) | 0 (0) | 1 (25) | 2 (50) | 1 (25) | — | 1 (25) | — | — | |
|
| ||||||||||||
|
| S | 2 (40) | 1 (20) | 3 (75) | 2 (40) | 3 (60) | 1 (20) | 3 (60) | 2 (40) | 3 (60) | 1 (20) | — |
| I | 1 (20) | 0 (0) | 1 (20) | 0 (0) | 0 (0) | 4 (80) | 0 (0) | 1 (20) | 1 (20) | 2 (40) | — | |
| R | 2 (40) | 4 (80) | 1 (20) | 3 (60) | 2 (40) | 0 (0) | 2 (40) | 2 (40) | 1 (20) | 2 (40) | — | |
|
| ||||||||||||
|
| S | 2 (50) | 0 (0) | 2 (50) | 3 (75) | 3 (75) | 2 (50) | 1 (25) | 2 (50) | 2 (50) | 2 (50) | — |
| I | 1 (25) | 1 (25) | 1 (25) | 1 (25) | 0 (0) | 0 (0) | 3 (75) | 1 (25) | 1 (25) | 0 (0) | — | |
| R | 1 (25) | 3 (75) | 1 (25) | 0 (0) | 1 (25) | 2 (50) | 0 (0) | 1 (25) | 1 (25) | 2 (50) | — | |
|
| ||||||||||||
|
| S | 2 (67) | 0 (0) | 2 (67) | 1 (33) | 2 (67) | 0 (0) | 2 (67) | 2 (67) | 2 (67) | 1 (33) | — |
| I | 0 (0) | 1 (33) | 1 (33) | 1 (33) | 1 (33) | 1 (33) | 1 (33) | 0 (0) | 0 (0) | 1 (33) | — | |
| R | 1 (33) | 2 (67) | 0 (0) | 1 (33) | 0 (0) | 2 (67) | 0 (0) | 1 (33) | 1 (33) | 1 (33) | — | |
|
| ||||||||||||
|
| S | 1 (50) | 1 (50) | 1 (50) | 2 (100) | 1 (50) | 2 (100) | 2 (100) | 0 (0) | 1 (50) | 2 (100) | — |
| I | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 0 (0) | 1 (50) | 1 (50) | 0 (0) | — | |
| R | 1 (50) | 1 (50) | 1 (50) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 0 (0) | — | |
|
| ||||||||||||
|
| S | 2 (50) | 1 (25) | 2 (50) | 2 (50) | 2 (50) | 1 (25) | 3 (75) | 0 (0) | — | — | 2 (50) |
| I | 1 (25) | 0 (0) | 1 (25) | 0 (0) | 1 (25) | 2 (50) | 0 (0) | 1 (25) | — | — | 1 (25) | |
| R | 1 (25) | 3 (75) | 1 (25) | 2 (50) | 1 (25) | 1 (25) | 1 (25) | 3 (75) | — | — | 1 (25) | |
|
| ||||||||||||
| CONS [ | S | 1 (50) | 0 (0) | 1 (50) | 0 (0) | 1 (50) | 2 (100) | 1 (50) | 1 (50) | — | — | 1 (50) |
| I | 0 (0) | 1 (50) | 1 (50) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (50) | — | — | 0 (0) | |
| R | 1 (50) | 1 (50) | 0 (0) | 2 (100) | 1 (50) | 0 (0) | 1 (50) | 0 (0) | — | — | 1 (50) | |
|
| ||||||||||||
|
| S | 1 (50) | 0 (0) | 2 (100) | 0 (0) | 1 (50) | 0 (0) | 1 (50) | 1 (50) | — | 0 (0) | — |
| I | 0 (0) | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 1 (50) | 1 (50) | 0 (0) | — | 1 (50) | — | |
| R | 1 (50) | 2 (100) | 0 (0) | 1 (50) | 1 (50) | 1 (50) | 0 (0) | 1 (50) | — | 1 (50) | — | |
AMC: amoxicillin; AMP: ampicillin; CPR: ciprofloxacin; CTR: ceftriaxone; CHL: chloramphenicol; CTX: ceftazidime; GN: gentamycin; TET: tetracycline; KAN: kanamycin; DOX: doxycycline; ERY: erythromycin; S: susceptible; I: intermediate; R: resistant.
Antibiotic susceptibility patterns of bacterial isolates from effluent released from Sikella Health Center.
| Bacterial isolates | Antimicrobial agents (frequency (percentage)) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMC | AMP | CPR | CTR | CHL | CTX | GN | TET | KAN | DOX | ERY | ||
|
| S | — | 0 (0) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | — | 1 (100) | — | — |
| I | — | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | — | 0 (0) | — | — | |
| R | — | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | — | 0 (0) | — | — | |
|
| ||||||||||||
|
| S | 2 (100) | 0 (0) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | — |
| I | 0 (0) | 1 (50) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | — | |
| R | 0 (0) | 1 (50) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | — | |
|
| ||||||||||||
|
| S | 2 (100) | 1 (50) | 1 (50) | 2 (100) | 1 (50) | 1 (50) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | — |
| I | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | — | |
| R | 0 (0) | 1 (50) | 1 (50) | 0 (0) | 1 (50) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | — | |
|
| ||||||||||||
|
| S | 1 (100) | 0 (0) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | — |
| I | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | — | |
| R | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | — | |
|
| ||||||||||||
|
| S | 1 (33) | 1 (33) | 2 (66) | 3 (100) | 2 (67) | 3 (100) | 1 (33) | 2 (67) | — | — | 3 (100) |
| I | 1 (33) | 1 (33) | 1 (33) | 0 (0) | 1 (33) | 0 (0) | 2 (67) | 0 (0) | — | — | 0 (0) | |
| R | 1 (33) | 1 (33) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (33) | — | — | 0 (0) | |
AMC: amoxicillin; AMP: ampicillin; CPR: ciprofloxacin; CTR: ceftriaxone; CHL: chloramphenicol; CTX: ceftazidime; GN: gentamycin; TET: tetracycline; KAN: kanamycin; DOX: doxycycline; ERY: erythromycin; S: susceptible; I: intermediate; R: resistant.
Antibiotic susceptibility patterns of bacterial isolates from effluent released from Secha Health Center.
| Bacterial isolates | Antimicrobial agents (frequency (percentage)) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMC | AMP | CPR | CTR | CHL | CTX | GN | TET | KAN | DOX | ERY | ||
|
| S | 2 (100) | 0 (0) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | — |
| I | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | — | |
| R | 0 (0) | 2 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | — | |
|
| ||||||||||||
|
| S | 2 (100) | 0 (0) | 1 (50) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 1 (50) | — |
| I | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | — | |
| R | 0 (0) | 2 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (50) | — | |
|
| ||||||||||||
|
| S | 2 (100) | 0 (0) | 2 (100) | 1 (50) | 2 (100) | 1 (50) | 2 (100) | 1 (50) | — | — | 2 (100) |
| I | 0 (0) | 1 (50) | 0 (0) | 1 (50) | 0 (0) | 1 (50) | 0 (0) | 0 (0) | — | — | 0 (0) | |
| R | 0 (0) | 1 (50) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (50) | — | — | 0 (0) | |
AMC: amoxicillin; AMP: ampicillin; CPR: ciprofloxacin; CTR: ceftriaxone; CHL: chloramphenicol; CTX: ceftazidime; GN: gentamycin; TET: tetracycline; KAN: kanamycin; DOX: doxycycline; ERY: erythromycin; S: susceptible; I: intermediate; R: resistant.